Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/15216
Full metadata record
DC FieldValueLanguage
dc.contributor.authorQadir, Muhammad Imran-
dc.date.accessioned2022-12-15T10:21:07Z-
dc.date.available2022-12-15T10:21:07Z-
dc.date.issued2016-01-20-
dc.identifier.citationQadir, M. I. (2016). Qadir test. Pak. J. Pharm. Sci, 29(1), 247-248.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/15216-
dc.description.abstractThe present diagnostic tests for cancers are expensive and are not accessible by poor. Therefore, it was necessary to explore a diagnostic test accessible by general public. Plasma lipid profile is decreased in all the cancers except in breast cancer, where HDL-cholesterol is decreased while the other lipids are increased. Therefore, plasma lipid profile may be used as diagnostic test for malignancy. As general diagnostic procedures, these laboratory parameters (plasma lipids) should also be co-related with the clinical symptoms of the patient and other diagnostic tools.en_US
dc.language.isoenen_US
dc.publisherKarachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.en_US
dc.subjectQadir testen_US
dc.subjectPlasma lipid profileen_US
dc.titleQadir testen_US
dc.typeArticleen_US
Appears in Collections:Issue 01

Files in This Item:
File Description SizeFormat 
Paper-34.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.